Pregnancy And Corticosteroids: What's Safe?

Corticosteroids are a group of medications that are relatively frequently administered during pregnancy for their immunosuppressive and anti-inflammatory effects. They are used to treat symptoms of autoimmune conditions, as well as skin, eye, and nasal conditions. While there have been concerns about the safety of corticosteroids in pregnancy, particularly regarding the risk of specific birth defects, preterm delivery, and low birth weight, the evidence is conflicting. Overall, topical corticosteroids appear to be safe during pregnancy, while the data on oral and systemic corticosteroids is inconsistent.

Corticosteroids are safe to use in pregnancy to control skin, eye and nose conditions

Corticosteroids are a group of medications that are used to treat a wide range of conditions, including skin, eye, and nose conditions. They are often used to suppress inflammation and immune responses. Corticosteroids can be administered in various forms, including oral, topical, and inhaled.

During pregnancy, it is natural for women to have concerns about the safety of medications they are taking. The good news is that topical corticosteroids are generally considered safe to use during pregnancy to control skin, eye, and nose conditions. Topical corticosteroids include creams or ointments applied to the skin, eye drops, and nasal sprays. If used as recommended, they are usually absorbed into the bloodstream in very small amounts, reducing the potential risks to the fetus.

While there are no known risks associated with topical corticosteroids during pregnancy, it is always sensible to follow the manufacturer's instructions and use the lowest effective dose to minimize any potential side effects. Pregnant women should consult their healthcare providers to ensure they are using the most suitable treatment option and to weigh the benefits against any possible risks.

In contrast, the use of oral corticosteroids during pregnancy has been associated with a slightly increased risk of certain birth defects, such as cleft lip or palate, as well as preterm delivery and low birth weight. However, these risks are relatively small, and the benefits of treating the underlying condition may outweigh the potential risks. It is important to note that the risks associated with oral corticosteroids may be related to the illnesses being treated rather than the medications themselves.

In summary, topical corticosteroids are generally safe to use during pregnancy to control skin, eye, and nose conditions. Pregnant women should consult their healthcare providers to ensure proper use and dosage, as well as to discuss any concerns or alternative treatment options.

Topical corticosteroids are absorbed into the bloodstream in small amounts

Topical corticosteroids are generally considered safe to use during pregnancy. They are applied directly to the skin to reduce inflammation and irritation. While they can be absorbed into the bloodstream, this occurs in very small amounts if used as recommended by the manufacturer.

Topical corticosteroids are available in various forms, such as skin creams, eye drops, and nasal sprays. They are commonly used to treat skin conditions like eczema, dermatitis, and psoriasis, as well as eye allergies and inflammation, and nasal allergies, sinusitis, and nasal polyps.

During pregnancy, topical corticosteroids can help control conditions affecting the skin, eyes, and nose, reducing inflammation and improving quality of life and sleep. They can also prevent infections caused by scratching. However, it is important to follow the manufacturer's instructions to ensure minimal absorption into the bloodstream.

Most adults and children can safely use topical corticosteroids, but they are not recommended for infected skin unless advised by a doctor. Mild corticosteroids, such as clobetasone and hydrocortisone, are often available over the counter, while stronger types like beclometasone and betamethasone require a prescription.

While topical corticosteroids are generally safe, there are some potential side effects to be aware of. These include a burning or stinging sensation, thinning of the skin, stretch marks, contact dermatitis, acne, and rosacea. Additionally, if potent or very potent topical corticosteroids are used for extended periods or over large areas, there is a risk of the medicine being absorbed into the bloodstream, potentially causing internal side effects such as decreased growth in children.

There are no known risks associated with topical corticosteroids

Topical corticosteroids are prescribed to up to 6% of pregnant women for skin conditions such as eczema, discoid lupus erythematosus, bullous pemphigoid, chronic plantar pustulosis, polymorphic eruption of pregnancy, and atopic eruptions during pregnancy.

In the past, there have been concerns about the association between topical corticosteroid use and orofacial clefts and restricted fetal growth, due to similar effects as those caused by systemically delivered steroids. However, several recent studies, including three cohort studies and one case-control study, did not detect a significant correlation between topical corticosteroid use in the first trimester of pregnancy and orofacial clefts.

Overall, topical corticosteroids appear to be safe during pregnancy. High-potency topical corticosteroids should be avoided if possible, and when they must be used, they should be used for the shortest period possible.

Oral corticosteroids carry a small increased risk of cleft lip or palate

Oral corticosteroids, such as prednisone, are used to treat a wide range of conditions, including asthma, autoimmune diseases, and skin conditions. They are relatively frequently administered during pregnancy, and their immunosuppressive and anti-inflammatory effects can be beneficial for both acute and chronic conditions. However, there have been concerns about the potential teratogenicity of corticosteroids, with some studies suggesting an increased risk for oral clefts in offspring.

The association between oral corticosteroids and oral clefts has been observed in some human epidemiological studies, but the results have been inconsistent. Earlier studies published in the early 2000s suggested a link between first-trimester corticosteroid use and an increased risk of cleft lip with or without cleft palate. However, more recent studies, including a 2014 update from the U.S. National Birth Defects Prevention Study (NBDPS), found no elevated risk for oral clefts with corticosteroid use.

The inconsistencies across studies may be due to a lack of information on drug dosage, indication for use, and the severity of the underlying maternal disease. It is possible that maternal disease or disease activity is directly linked to oral clefts, or that corticosteroids are associated with an increased risk through co-occurring exposures such as smoking, alcohol, or obesity.

While the current evidence does not strongly support an association between oral corticosteroids and oral clefts, it is important to note that the safety of corticosteroid medication during pregnancy is still uncertain. Pregnant women and those planning a pregnancy should consult with their healthcare providers to weigh the benefits of treating their condition against any possible risks to the pregnancy.

Corticosteroids are not expected to increase the chance of miscarriage

However, it is important to note that the use of corticosteroids during pregnancy has been associated with a slightly increased risk of early miscarriage, particularly for inhaled corticosteroids. This risk is slightly higher for current users of inhaled corticosteroids, defined as those who filled a prescription within 60 days before the miscarriage or index date. The adjusted odds ratio for miscarriage associated with current use of inhaled corticosteroids was 1.2 in one study, while another study found a relative risk of 1.7. These results suggest a potential link between corticosteroid use and early miscarriage, but the evidence is not conclusive, and other factors may also be involved.

Furthermore, it is worth noting that the use of corticosteroids during pregnancy has been a subject of debate regarding the risk of specific birth defects, preterm delivery, and low birth weight. While corticosteroids have been suspected to be teratogenic for many years, the evidence regarding their association with congenital malformations is inconsistent. Overall, the current evidence suggests that the use of corticosteroids in early pregnancy is not associated with an increased risk of congenital malformations or oral clefts in offspring.

In conclusion, while corticosteroid use during pregnancy may slightly increase the risk of early miscarriage, particularly for inhaled corticosteroids, it is not expected to increase the overall chance of miscarriage. Pregnant women should consult their healthcare providers before making any changes to their medication to weigh the benefits of treating their condition against any potential risks to the pregnancy.

Frequently asked questions